TrialThe oncologist2019

Randomized Phase II Study of Weekly Paclitaxel plus Carboplatin Versus Biweekly Paclitaxel plus Carboplatin for Patients with Previously Untreated Advanced Non-Small Cell Lung Cancer.

Koichi Takayama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.